{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T22:52:32Z","timestamp":1790031152105,"version":"4.0.1"},"reference-count":118,"publisher":"Oxford University Press (OUP)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,8,1]]},"DOI":"10.1093\/jac\/dku104","type":"journal-article","created":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T10:39:01Z","timestamp":1398940741000},"page":"2032-2042","source":"Crossref","is-referenced-by-count":50,"title":["Drug resistance in the HIV-1-infected paediatric population worldwide: a systematic review"],"prefix":"10.1093","volume":"69","author":[{"given":"Patricia","family":"Rojas S\u00e1nchez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Africa","family":"Holgu\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,4,30]]},"reference":[{"key":"key\n\t\t\t\t20170425183911_DKU104C1","article-title":"UNAIDS report on the global AIDS epidemic 2013","author":"Global report"},{"key":"key\n\t\t\t\t20170425183911_DKU104C2","author":"WHO, UNICEF, UNAIDS"},{"key":"key\n\t\t\t\t20170425183911_DKU104C3","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1086\/427287","article-title":"Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy","volume":"40","author":"European Collaborative Study","year":"2005","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170425183911_DKU104C4","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1468-1293.2009.00759.x","article-title":"PENTA 2009 guidelines for the use of antiretroviral therapy in paediatric HIV-1 infection","volume":"10","author":"PENTA Steering Committee","year":"2009","journal-title":"HIV Med"},{"key":"key\n\t\t\t\t20170425183911_DKU104C5","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1086\/521167","article-title":"Collaborative HIV Paediatric Study (CHIPS); National Study of HIV in Pregnancy and Childhood (NSHPC). Morbidity, mortality, and response to treatment by children in the United Kingdom and Ireland with perinatally acquired HIV infection during 1996\u20132006: planning for teenage and adult care","volume":"45","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170425183911_DKU104C6","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1742-4690-6-85","article-title":"Perinatal acquisition of drug-resistant HIV-1 infection: mechanisms and long-term outcome","volume":"6","author":"ANRS French Perinatal Cohort","year":"2009","journal-title":"Retrovirology"},{"key":"key\n\t\t\t\t20170425183911_DKU104C7","author":"Guidelines for the use of antiretroviral agents in pediatric HIV infection"},{"key":"key\n\t\t\t\t20170425183911_DKU104C8","author":"Panel on Antiretroviral Therapy and Medical Management of HIV-infected Children"},{"key":"key\n\t\t\t\t20170425183911_DKU104C9","article-title":"Recommendations for a public health approach","author":"WHO The use of antiretroviral drugs for treating and preventing HIV infection"},{"key":"key\n\t\t\t\t20170425183911_DKU104C10","article-title":"Tratamiento antirretroviral de la infecci\u00f3n por el VIH en ni\u00f1os en Latinoam\u00e9rica y el Caribe: en la ruta hacia el acceso universal. Recomendaciones para un enfoque de salud p\u00fablica","author":"Organizaci\u00f3n Panamericana de la Salud"},{"key":"key\n\t\t\t\t20170425183911_DKU104C11","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/INF.0b013e31824580e8","article-title":"Potent and sustained antiviral response of raltegravir-based highly active antiretroviral therapy in HIV type 1-infected children and adolescents","volume":"31","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20170425183911_DKU104C12","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/S0140-6736(11)60208-0","article-title":"Risk of triple-class virological failure in children with HIV: a retrospective cohort study PLATO II","volume":"377","author":"Pursuing Later Treatment Options II (PLATO II) project team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE)","year":"2011","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170425183911_DKU104C13","article-title":"US Food and Drug Administration","author":"Antiretroviral Drugs Used in the Treatment of HIV Infection"},{"key":"key\n\t\t\t\t20170425183911_DKU104C14","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1086\/513871","article-title":"Pediatric AIDS Clinical Trials Group P1030 Team. Early archiving and predominance of nonnucleoside reverse transcriptase inhibitor-resistant HIV-1 among recently infected infants born in the United States","volume":"195","year":"2007","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170425183911_DKU104C15","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3851\/IMP2562","article-title":"Prevalence and determinants of virological failure in HIV-infected children on antiretroviral therapy in rural Cameroon: a cross-sectional study","volume":"18","year":"2013","journal-title":"Antivir Ther"},{"key":"key\n\t\t\t\t20170425183911_DKU104C16","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1056\/NEJMra025195","article-title":"HIV drug resistance","volume":"350","year":"2004","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170425183911_DKU104C17","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/QAI.0b013e31814278c0","article-title":"Predictors of long-term viral failure among Ugandan children and adults treated with antiretroviral therapy","volume":"46","author":"Academic Alliance for AIDS Care and Prevention in Africa","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20170425183911_DKU104C18","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/QAI.0b013e318229f2a2","article-title":"Drug resistance profiles among HIV-1 infected children experiencing delayed switch and 12-month efficacy after using second-line antiretroviral therapy: an observational cohort study in rural China","volume":"58","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20170425183911_DKU104C19","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1089\/aid.2012.0283","article-title":"Antiretroviral drug resistance profiles and response to second-line therapy among HIV type 1-infected Ugandan children","volume":"29","year":"2013","journal-title":"AIDS Res Hum Retroviruses"},{"key":"key\n\t\t\t\t20170425183911_DKU104C20","first-page":"25","article-title":"Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatment","volume":"12","year":"2008","journal-title":"Antiviral Ther"},{"key":"key\n\t\t\t\t20170425183911_DKU104C21","author":"WHO. HIV Resistance Report 2012"},{"key":"key\n\t\t\t\t20170425183911_DKU104C22","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S1473-3099(11)70141-4","article-title":"HIV-1-resistance-associated mutations after failure of first-line antiretroviral treatment among children in resource-poor regions: a systematic review","volume":"11","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20170425183911_DKU104C23","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/QAI.0b013e31827b4ac8","article-title":"Long-term virologic response and genotypic resistance mutations in HIV-1 infected Kenyan children on combination antiretroviral therapy","volume":"62","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20170425183911_DKU104C24","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1089\/aid.2011.0035","article-title":"Virological response and resistance profiles after 18 to 30 months of first- or second-\/third-line antiretroviral treatment: a cross-sectional evaluation in HIV type 1-infected children living in the Central African Republic","volume":"28","year":"2012","journal-title":"AIDS Res Hum Retroviruses"},{"key":"key\n\t\t\t\t20170425183911_DKU104C25","doi-asserted-by":"crossref","first-page":"18579","DOI":"10.7448\/IAS.16.1.18579","article-title":"Antiretroviral treatment, management challenges and outcomes in perinatally HIV-infected adolescents","volume":"16","year":"2013","journal-title":"J Int AIDS Soc"},{"key":"key\n\t\t\t\t20170425183911_DKU104C26","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1089\/apc.2008.0153","article-title":"Collaborative HIV Paediatric Study (CHIPS). Young people in the United Kingdom and Ireland with perinatally acquired HIV: the pediatric legacy for adult services","volume":"23","year":"2009","journal-title":"AIDS Patient Care STDs"},{"key":"key\n\t\t\t\t20170425183911_DKU104C27","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1086\/653674","article-title":"Long-term outcomes in adolescents perinatally infected with HIV-1 and followed up since birth in the French perinatal cohort (EPF\/ANRS CO10)","volume":"51","year":"2010","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170425183911_DKU104C28","doi-asserted-by":"crossref","first-page":"e52155","DOI":"10.1371\/journal.pone.0052155","article-title":"Madrid Cohort of HIV-infected Children. High drug resistance prevalence among vertically HIV-infected patients transferred from pediatric care to adult units in Spain","volume":"7","year":"2012","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170425183911_DKU104C29","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-2334-12-21","article-title":"Treatment outcomes in HIV-infected adolescents attending a community-based antiretroviral therapy clinic in South Africa","volume":"12","year":"2012","journal-title":"BMC Infect Dis"},{"key":"key\n\t\t\t\t20170425183911_DKU104C30","author":"WHO. Global HIV Drug Resistance Network"},{"key":"key\n\t\t\t\t20170425183911_DKU104C31","doi-asserted-by":"crossref","first-page":"17324","DOI":"10.7448\/IAS.15.2.17324","article-title":"Challenges and opportunities for the implementation of virological testing in resource-limited settings","volume":"15","year":"2012","journal-title":"J Int AIDS Soc"},{"key":"key\n\t\t\t\t20170425183911_DKU104C32","author":"WHO. Generic Protocol for Surveillance of Initial Drug-resistant HIV-1 Among Children <18 Months of Age Newly Diagnosed with HIV"},{"key":"key\n\t\t\t\t20170425183911_DKU104C33","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jviromet.2012.11.044","article-title":"Performance of the ViroSeq HIV-1 genotyping system v2.0 on HIV-1 strains circulating in Senegal","volume":"188","year":"2013","journal-title":"J Virol Methods"},{"key":"key\n\t\t\t\t20170425183911_DKU104C34","first-page":"212","article-title":"Role of genetic diversity amongst HIV-1 non-B subtypes in drug resistance: a systematic review of virologic and biochemical evidence","volume":"10","year":"2008","journal-title":"AIDS Rev"},{"key":"key\n\t\t\t\t20170425183911_DKU104C35","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1093\/jac\/dkt012","article-title":"Subtype-specific differences in the development of accessory mutations associated with high-level resistance to HIV-1 nucleoside reverse transcriptase inhibitors","volume":"68","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170425183911_DKU104C36","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1586\/14787210.2013.844649","article-title":"HIV-1 genetic variation and drug resistance development","volume":"11","year":"2013","journal-title":"Expert Rev Anti Infect Ther"},{"key":"key\n\t\t\t\t20170425183911_DKU104C37","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1093\/jac\/dkt173","article-title":"Structural modifications induced by specific HIV-1 protease-compensatory mutations have an impact on the virological response to a first-line lopinavir\/ritonavir-containing regimen","volume":"68","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170425183911_DKU104C38","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1086\/590943","article-title":"Emergence of drug resistance in HIV type 1-infected patients after receipt of first-line highly active antiretroviral therapy: a systematic review of clinical trials","volume":"47","year":"2008","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170425183911_DKU104C39","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/S0140-6736(12)61038-1","article-title":"Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis","volume":"380","year":"2012","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170425183911_DKU104C40","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S1473-3099(11)70032-9","article-title":"Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study","volume":"11","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20170425183911_DKU104C41","doi-asserted-by":"crossref","first-page":"e26757","DOI":"10.1371\/journal.pone.0026757","article-title":"Increase of transmitted drug resistance among HIV-infected sub-Saharan Africans residing in Spain in contrast to the native population","volume":"6","year":"2011","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170425183911_DKU104C42","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/1471-2334-12-317","article-title":"High viremia and low level of transmitted drug resistance in anti-retroviral therapy-naive perinatally-infected children and adolescents with HIV-1 subtype C infection","volume":"12","year":"2012","journal-title":"BMC Infect Dis"},{"key":"key\n\t\t\t\t20170425183911_DKU104C43","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1097\/INF.0b013e31822db54c","article-title":"Drug resistance among drug-naive and first-line antiretroviral treatment-failing children in Cameroon","volume":"30","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20170425183911_DKU104C44","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1089\/aid.2009.0164","article-title":"Analysis of drug resistance in children receiving antiretroviral therapy for treatment of HIV-1 infection in Uganda","volume":"26","year":"2010","journal-title":"AIDS Res Hum Retroviruses"},{"key":"key\n\t\t\t\t20170425183911_DKU104C45","doi-asserted-by":"crossref","first-page":"e213","DOI":"10.1097\/INF.0b013e3182678c7c","article-title":"Trends in drug resistance prevalence in HIV-1 infected children in Madrid: 1993 to 2010 analysis","volume":"31","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20170425183911_DKU104C46","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/00126334-200303010-00008","article-title":"Prevalence of genotypic drug resistance among a cohort of HIV-infected newborns","volume":"32","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20170425183911_DKU104C47","doi-asserted-by":"crossref","first-page":"e255","DOI":"10.1097\/INF.0b013e3182684d8e","article-title":"Prevalence of transmitted HIV-1 drug resistance mutations in children and adolescents in S\u00e3o Paulo, Brazil","volume":"31","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20170425183911_DKU104C48","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1590\/S0074-02762003000600021","article-title":"Human immunodeficiency virus type 1: drug resistance in treated and untreated Brazilian children","volume":"98","year":"2003","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"key\n\t\t\t\t20170425183911_DKU104C49","first-page":"407476","article-title":"HIV drug resistance-associated mutations in antiretroviral naive HIV-1 infected Latin American children","volume":"2010","year":"2010","journal-title":"Adv Virol"},{"key":"key\n\t\t\t\t20170425183911_DKU104C50","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1097\/INF.0b013e3182117289","article-title":"Drug resistance prevalence in human immunodeficiency virus type 1 infected pediatric populations in Honduras and El Salvador during 1989\u20132009","volume":"30","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20170425183911_DKU104C51","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1089\/aid.2010.0289","article-title":"Short communication: High prevalence of drug resistance in HIV type 1-infected children born in Honduras and Belize 2001 to 2004","volume":"27","year":"2011","journal-title":"AIDS Res Hum Retroviruses"},{"key":"key\n\t\t\t\t20170425183911_DKU104C52","doi-asserted-by":"crossref","first-page":"24","DOI":"10.37757\/MR2011V13.N2.7","article-title":"Drug-resistant HIV-1 in Cuban children and their seropositive mothers","volume":"13","year":"2011","journal-title":"MEDICC Rev"},{"key":"key\n\t\t\t\t20170425183911_DKU104C53","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1590\/S1020-49892011001200025","article-title":"HIV transmitted drug resistance in adult and pediatric populations in Panama","volume":"30","year":"2011","journal-title":"Rev Panam Salud P\u00fablica"},{"key":"key\n\t\t\t\t20170425183911_DKU104C54","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/INF.0b013e3181646d6f","article-title":"HIV-1 drug resistance in HIV-1 infected children in the United Kingdom from 1998 to 2004","volume":"27","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20170425183911_DKU104C55","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1097\/INF.0b013e31821752d6","article-title":"Lopinavir\/ritonavir-based antiretroviral therapy in human immunodeficiency virus type 1-infected naive children: rare protease inhibitor resistance mutations but high lamivudine\/emtricitabine resistance at the time of virologic failure","volume":"30","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20170425183911_DKU104C56","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/01.qai.0000225871.87456.e7","article-title":"Prevalence of drug-resistance mutations and non-subtype B strains among HIV-infected infants from New York State","volume":"42","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20170425183911_DKU104C57","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/jmv.20912","article-title":"Anti-retroviral drug resistance-associated mutations among non-subtype B HIV-1 infected Kenya children with treatment failure","volume":"79","year":"2007","journal-title":"J Med Virol"},{"key":"key\n\t\t\t\t20170425183911_DKU104C58","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1089\/aid.2010.0205","article-title":"Rapid development of antiretroviral drug resistance mutations in HIV-infected children less than two years of age initiating protease inhibitor-based therapy in South Africa","volume":"27","year":"2011","journal-title":"AIDS Res Hum Retroviruses"},{"key":"key\n\t\t\t\t20170425183911_DKU104C59","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/jac\/dkp412","article-title":"Level of viral load and antiretroviral resistance after 6 months of non-nucleoside reverse transcriptase inhibitor first-line treatment in HIV-1 infected children in Mali","volume":"65","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170425183911_DKU104C60","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1097\/01.inf.0000190413.88671.92","article-title":"Genotypic human immunodeficiency virus type 1 drug resistance in highly active antiretroviral therapy-treated children in Abidjan, C\u00f4te d'Ivoire","volume":"24","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20170425183911_DKU104C61","doi-asserted-by":"crossref","first-page":"e283","DOI":"10.1097\/INF.0b013e3181ba6c92","article-title":"Risk of extended viral resistance in human immunodeficiency virus-1-infected Mozambican children after first-line treatment failure","volume":"28","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20170425183911_DKU104C62","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1093\/cid\/cir008","article-title":"Initiation of antiretroviral treatment in women after delivery can induce multiclass drug resistance in breastfeeding HIV-infected infants","volume":"52","year":"2011","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170425183911_DKU104C63","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/INF.0b013e31827f44ee","article-title":"Impact of maternal and infant antiretroviral drug regimens on drug resistance in HIV-infected breastfeeding infants","volume":"32","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20170425183911_DKU104C64","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1089\/aid.2011.0300","article-title":"High rate of antiretroviral drug resistance mutations in HIV type 1-infected Senegalese children in virological failure on first-line treatment according to the World Health Organization guidelines","volume":"29","year":"2013","journal-title":"AIDS Res Hum Retroviruses"},{"key":"key\n\t\t\t\t20170425183911_DKU104C65","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1089\/aid.2009.0003","article-title":"In utero HIV infection is associated with an increased risk of nevirapine resistance in Ugandan infants who were exposed to perinatal single dose nevirapine","volume":"25","year":"2009","journal-title":"AIDS Res Hum Retroviruses"},{"key":"key\n\t\t\t\t20170425183911_DKU104C66","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/QAI.0b013e3181fbcbf7","article-title":"Early virologic failure and the development of antiretroviral drug resistance mutations in HIV-infected Ugandan children","volume":"56","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20170425183911_DKU104C67","doi-asserted-by":"crossref","first-page":"565","DOI":"10.5144\/0256-4947.2012.565","article-title":"Antiretroviral resistance in HIV-infected Saudi children failing first-line highly active antiretroviral therapy","volume":"32","year":"2012","journal-title":"Ann Saudi Med"},{"key":"key\n\t\t\t\t20170425183911_DKU104C68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2334-13-1","article-title":"Antiviral resistance and correlates of virologic failure in the first cohort of HIV-infected children gaining access to structured antiretroviral therapy in Lima, Peru: a cross-sectional analysis","volume":"13","year":"2013","journal-title":"BMC Infect Dis"},{"key":"key\n\t\t\t\t20170425183911_DKU104C69","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.meegid.2008.10.002","article-title":"Distinct resistance mutation and polymorphism acquisition in HIV-1 protease of subtype B and F1 from children and adults patients under virological failure","volume":"9","year":"2009","journal-title":"Infect Genet Evol"},{"key":"key\n\t\t\t\t20170425183911_DKU104C70","first-page":"60","article-title":"HIV-1 drug resistance genotypic profiles in children with undetectable plasma viremia during antiretroviral therapy","volume":"15","year":"2011","journal-title":"Braz J Infect Dis"},{"key":"key\n\t\t\t\t20170425183911_DKU104C71","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1468-1293.2010.00828.x","article-title":"HIV-1 drug resistance mutations in children after failure of first-line nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy","volume":"11","author":"HIV-NAT 086 Study Team","year":"2010","journal-title":"HIV Med"},{"key":"key\n\t\t\t\t20170425183911_DKU104C72","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1086\/427026","article-title":"Resistance to dual nucleoside reverse-transcriptase inhibitors in children infected with HIV clade A\/E","volume":"40","year":"2005","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170425183911_DKU104C73","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1093\/cid\/cis433","article-title":"Prediction of treatment failure using 2010 World Health Organization guidelines is associated with high misclassification rates and drug resistance among HIV-infected Cambodian children","volume":"55","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170425183911_DKU104C74","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S1413-8670(12)70325-2","article-title":"Assessing subtypes and drug resistance mutations among HIV-1 infected children who failed antiretroviral therapy in Kelantan, Malaysia","volume":"16","year":"2012","journal-title":"Braz J Infect Dis"},{"key":"key\n\t\t\t\t20170425183911_DKU104C75","doi-asserted-by":"crossref","first-page":"e227","DOI":"10.1097\/INF.0b013e31827fb2d1","article-title":"Effectiveness of first-line antiretroviral therapy and acquired drug resistance among HIV-1 infected children in India","volume":"32","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20170425183911_DKU104C76","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/hiv.12089","article-title":"HIV-1 drug resistance prevalence, drug susceptibility and variant characterization in the Jacobi Medical Center Pediatric Cohort, Bronx, NY, USA","volume":"15","year":"2014","journal-title":"HIV Med"},{"key":"key\n\t\t\t\t20170425183911_DKU104C77","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/cid\/cis006","article-title":"Surveillance of HIV drug resistance in children receiving antiretroviral therapy: a pilot study of the World Health Organization's generic protocol in Maputo, Mozambique","volume":"54","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170425183911_DKU104C78","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.antiviral.2010.10.008","article-title":"Cohort of Spanish AIDS Research Network (CoRIS). Sensitivity of seven HIV subtyping tools differs among subtypes\/recombinants in the Spanish cohort of naive HIV-infected patients (CoRIS)","volume":"89","year":"2011","journal-title":"Antiviral Res"},{"key":"key\n\t\t\t\t20170425183911_DKU104C79","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/QAD.0b013e328342ff93","article-title":"WHO-UNAIDS Network for HIV Isolation and Characterisation. Global trends in molecular epidemiology of HIV-1 during 2000\u20132007","volume":"25","year":"2011","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20170425183911_DKU104C80","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2174\/157016208785132455","article-title":"Increase of non-B subtypes and recombinants among newly diagnosed HIV-1 native Spaniards and immigrants in Spain","volume":"6","year":"2008","journal-title":"Curr HIV Res"},{"key":"key\n\t\t\t\t20170425183911_DKU104C81","doi-asserted-by":"crossref","first-page":"10755","DOI":"10.1128\/JVI.00454-11","article-title":"Molecular surveillance of HIV-1 in Madrid, Spain: a phylogeographic analysis","volume":"85","year":"2011","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20170425183911_DKU104C82","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1128\/JCM.05798-11","article-title":"Cohort of the Spanish AIDS Research Network (CoRIS). Most HIV type 1 non-B infections in Spanish cohort of antiretroviral treatment-naive HIV-infected patients (CoRIS) are due to recombinant virases","volume":"50","year":"2012","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20170425183911_DKU104C83","doi-asserted-by":"crossref","first-page":"e523","DOI":"10.1111\/1469-0691.12264","article-title":"Transmitted drug-resistance in human immunodeficiency virus-infected adult population in El Salvador, Central America","volume":"19","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20170425183911_DKU104C84","doi-asserted-by":"crossref","first-page":"7463","DOI":"10.1128\/JVI.01602-12","article-title":"Single early introduction of HIV-1 subtype B into Central America accounts for most current cases","volume":"87","year":"2013","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20170425183911_DKU104C85","doi-asserted-by":"crossref","first-page":"e69218","DOI":"10.1371\/journal.pone.0069218","article-title":"Reconstructing the timing and dispersion routes of HIV-1 subtype B epidemics in the Caribbean and Central America: a phylogenetic story","volume":"8","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170425183911_DKU104C86","doi-asserted-by":"crossref","first-page":"e62552","DOI":"10.1371\/journal.pone.0062552","article-title":"Variability of HIV-1 genomes among children and adolescents from S\u00e3o Paulo, Brazil","volume":"8","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170425183911_DKU104C87","article-title":"Identification of a novel HIV type 1 circulating recombinant form (CRF65_cpx) composed of CRF01_AE and subtypes B and C in western Yunnan, China","year":"2014","journal-title":"AIDS Res Hum Retroviruses"},{"key":"key\n\t\t\t\t20170425183911_DKU104C88","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/01.qai.0000186361.42834.61","article-title":"Prevalence of transmitted HIV-1 drug resistance and the role of resistance algorithms: data from seroconverters in the CASCADE collaboration from 1987 to 2003","volume":"40","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20170425183911_DKU104C89","first-page":"377","article-title":"HIV-1 non-B subtypes in Italy: a growing trend","volume":"35","year":"2012","journal-title":"New Microbiol"},{"key":"key\n\t\t\t\t20170425183911_DKU104C90","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1093\/infdis\/jir491","article-title":"The role of migration and domestic transmission in the spread of HIV-1 non-B subtypes in Switzerland","volume":"204","author":"Swiss HIV Cohort Study","year":"2011","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170425183911_DKU104C91","first-page":"481314","article-title":"HIV-1 genetic variability and clinical implications","volume":"2013","year":"2013","journal-title":"ISRN Microbiol"},{"key":"key\n\t\t\t\t20170425183911_DKU104C92","first-page":"98","article-title":"Efficacy of antiretroviral therapy in individuals infected with HIV-1 non-B subtypes","volume":"8","year":"2006","journal-title":"AIDS Rev"},{"key":"key\n\t\t\t\t20170425183911_DKU104C93","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1086\/499952","article-title":"Different rates of disease progression of HIV type 1 infection in Tanzania based on infecting subtype","volume":"42","year":"2006","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170425183911_DKU104C94","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1758-2652-13-4","article-title":"Impact of HIV-1 viral subtype on disease progression and response to antiretroviral therapy","volume":"13","year":"2010","journal-title":"J Int AIDS Soc"},{"key":"key\n\t\t\t\t20170425183911_DKU104C95","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/QAI.0b013e3181c1d456","article-title":"Infection with different HIV subtypes is associated with CD4 activation-associated dysfunction and apoptosis","volume":"52","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20170425183911_DKU104C96","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1093\/cid\/cis1000","article-title":"CASCADE Collaboration in EuroCoord. Impact of HIV-1 subtype on CD4 count at HIV seroconversion, rate of decline, and viral load set point in European seroconverter cohorts","volume":"56","year":"2013","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170425183911_DKU104C97","first-page":"195","article-title":"Dried blood spots for HIV-1 drug resistance and viral load testing: a review of current knowledge and WHO efforts for global HIV drug resistance surveillance","volume":"12","year":"2010","journal-title":"AIDS Rev"},{"key":"key\n\t\t\t\t20170425183911_DKU104C98","first-page":"100","article-title":"Dried blood spots for monitoring HIV infection in public health programs in developing countries","volume":"31","year":"2013","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"key\n\t\t\t\t20170425183911_DKU104C99","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S1473-3099(11)70149-9","article-title":"HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study","volume":"11","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20170425183911_DKU104C100","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/QAI.0b013e31817ae5c0","article-title":"EuroSIDA Study Group. Transmitted drug resistant HIV-1 and association with virologic and CD4 cell count response to combination antiretroviral therapy in the EuroSIDA study","volume":"48","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20170425183911_DKU104C101","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1086\/644505","article-title":"Transmission of drug-resistant HIV-1 is stabilizing in Europe","volume":"200","year":"2009","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170425183911_DKU104C102","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/QAD.0b013e328326ca77","article-title":"Stable frequency of HIV-1 transmitted drug resistance in patients at the time of primary infection over 1996\u20132006 in France","volume":"23","year":"2009","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20170425183911_DKU104C103","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1097\/QAD.0b013e3280b07761","article-title":"Evidence of a decline in transmitted HIV-1 drug resistance in the United Kingdom","volume":"21","author":"UK Collaborative Group on HIV Drug Resistance, UK Collaborative HIV Cohort Study, UK Register of HIV Seroconverters","year":"2007","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20170425183911_DKU104C104","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1086\/367989","article-title":"Transmission fitness of drug resistant human immunodeficiency virus and the prevalence of resistance in the antiretroviral treated population","volume":"187","year":"2003","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170425183911_DKU104C105","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1177\/135965350601100208","article-title":"CASCADE Collaboration. Evolution of transmitted HIV-1 with drug-resistance mutations in the absence of therapy: effects on CD4+ T-cell count and HIV-1 RNA load","volume":"11","year":"2006","journal-title":"Antivir Ther"},{"key":"key\n\t\t\t\t20170425183911_DKU104C106","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1097\/01.aids.0000131377.28694.04","article-title":"Persistence of multidrug-resistant HIV-1 in primary infection leading to superinfection","volume":"18","year":"2004","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20170425183911_DKU104C107","doi-asserted-by":"crossref","first-page":"e20357","DOI":"10.1371\/journal.pone.0020357","article-title":"Emergence and persistence of minor drug-resistant HIV-1 variants in Ugandan women after nevirapine single-dose prophylaxis","volume":"6","year":"2011","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170425183911_DKU104C108","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1086\/511433","article-title":"Persistence of K103N-containing HIV-1 variants after single-dose nevirapine for prevention of HIV-1 mother-to-child transmission","volume":"195","year":"2007","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170425183911_DKU104C109","volume-title":"Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants","author":"WHO"},{"key":"key\n\t\t\t\t20170425183911_DKU104C110","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3851\/IMP2437","article-title":"Rates of emergence of HIV drug resistance in resource-limited settings: a systematic review","volume":"18","year":"2013","journal-title":"Antivir Ther"},{"key":"key\n\t\t\t\t20170425183911_DKU104C111","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1093\/cid\/cir729","article-title":"Immunologic criteria are poor predictors of virologic outcome: implications for HIV treatment monitoring in resource-limited settings","volume":"53","year":"2011","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170425183911_DKU104C112","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/QAI.0b013e318186eb18","article-title":"CD4+ T-cell count monitoring does not accurately identify HIV-infected adults with virologic failure receiving antiretroviral therapy","volume":"49","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20170425183911_DKU104C113","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/QAI.0b013e3182060610","article-title":"Virologic failure and second-line antiretroviral therapy in children in South Africa: the IeDEA Southern Africa collaboration","volume":"56","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20170425183911_DKU104C114","doi-asserted-by":"crossref","first-page":"e4724","DOI":"10.1371\/journal.pone.0004724","article-title":"Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update","volume":"4","year":"2009","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170425183911_DKU104C115","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/QAD.0b013e3283352ef1","article-title":"Addition of extended zidovudine to extended nevirapine prophylaxis reduces nevirapine resistance in infants who were HIV-infected in utero","volume":"24","year":"2010","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20170425183911_DKU104C116","doi-asserted-by":"crossref","first-page":"e1000172","DOI":"10.1371\/journal.pmed.1000172","article-title":"Efficacy of short-course AZT plus 3TC to reduce nevirapine resistance in the prevention of mother-to-child HIV transmission: a randomized clinical trial","volume":"6","year":"2009","journal-title":"PLoS Med"},{"key":"key\n\t\t\t\t20170425183911_DKU104C117","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.3851\/IMP1461","article-title":"Evaluation of minority populations of HIV type-1 with K103N and M184V drug resistance mutations among children in Argentina","volume":"14","year":"2009","journal-title":"Antivir Ther"},{"key":"key\n\t\t\t\t20170425183911_DKU104C118","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/infdis\/jit115","article-title":"Development of antiretroviral resistance in children with HIV in low- and middle-income countries","volume":"207","year":"2013","journal-title":"J Infect Dis"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,5,26]],"date-time":"2024-05-26T08:29:29Z","timestamp":1716712169000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article-lookup\/doi\/10.1093\/jac\/dku104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,30]]},"references-count":118,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2014,4,30]]},"published-print":{"date-parts":[[2014,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dku104","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,30]]}}}